Ascendis Pharma
ASND
#1501
Rank
โ‚น1.397 T
Marketcap
โ‚น22,614
Share price
-0.43%
Change (1 day)
72.16%
Change (1 year)

Revenue for Ascendis Pharma (ASND)

Revenue in 2026 (TTM): โ‚น91.02 Billion

According to Ascendis Pharma 's latest financial reports the company's current revenue (TTM ) is โ‚น96.41 Billion. In 2025 the company made a revenue of โ‚น75.13 Billion an increase over the revenue in the year 2024 that were of โ‚น33.24 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Ascendis Pharma from 2014 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚น91.02 B21.15%
2025 โ‚น75.13 B126.01%
2024 โ‚น33.24 B37.09%
2023 โ‚น24.24 B447.4%
2022 โ‚น4.42 B567.18%
2021 โ‚น0.66 B14.09%
2020 โ‚น0.58 B-45.52%
2019 โ‚น1.06 B26.17%
2018 โ‚น0.84 B657.64%
2017 โ‚น0.11 B-67.76%
2016 โ‚น0.34 B-41.56%
2015 โ‚น0.59 B-49.14%
2014 โ‚น1.16 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Akebia Therapeutics
AKBA
โ‚น21.41 B-77.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Affimed
AFMD
โ‚น91.52 M-99.91%๐Ÿ‡ฉ๐Ÿ‡ช Germany
Advaxis
ADXS.defunct
โ‚น10.84 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA